Life Sciences Funds Continue to Struggle in 2022

Most were down by double-digits in the first quarter.

Nicky Loh/Bloomberg

Nicky Loh/Bloomberg

Life sciences hedge funds picked up in the first quarter where they left off last year.

And that’s not a good thing.

Many of them not only lost money for the three-month period, they suffered another round of double-digit losses following last year’s disastrous declines.


To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.